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Abstract
Background: Previously, it was shown that the HFE gene (associated with human hereditary hemochromatosis) has
several haplotypes of intronic polymorphisms. Some haplotype frequencies are race specific and hence can be used
in phylogenetic analysis. We assumed that analysis of Caucasoid patients—living now in Western Siberia and
having diseases associated with dietary habits and metabolic rate—will allow us to understand the processes of
possible selection during settling of the northern part of Asia.
Results: Haplotype analysis of Northern Eurasian native and recently settled ethnic groups was performed on
polymorphisms rs1799945, rs1800730, rs1800562, rs2071303, rs1800708, rs1572982, rs2794719, rs807209, and
rs2032451 of this gene. The CCA haplotype of the rs2071303, rs1800708, and rs1572982 was found to be associated
with HLA-A2 (39 %) in Asian populations. Haplotype analysis for the rs1799945, rs1800730, rs1800562, rs2071303,
rs1800708, and rs1572982 was performed on Russian patients with some metabolic disorders or stomach cancer
and among long-lived people. Decreased frequencies of the TTA haplotype (T in rs2071303, T in rs1800708, and A
in rs1572982) were observed in the groups of patients with diseases associated with overweight (fatty liver disease,
type 2 diabetes mellitus, or metabolic syndrome + arterial hypertension) as compared with the control sample. We
detected significant differences in this haplotype’s frequency between the patients with type 2 diabetes mellitus
and Russian adolescents, elderly citizens, and long-lived people (χ2 P value = 0.003, 0.010, and 0.015, respectively).
Conclusions: No significant differences in frequencies of the alleles with mutations in coding regions of the HFE
gene (C282Y, H63D, and S65C) were detected between the analyzed patients (with stomach cancer, metabolic
syndrome, fatty liver disease, or type 2 diabetes mellitus) and the control Caucasoid sample. Monophyletic origin of
H63D (rs1799945) was confirmed in Caucasoids and Northern Asians. The reasons for a sharp increase in the
frequency of CCA haplotype of HFE in the Asian race remain unclear.
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Background
It is known that single-nucleotide polymorphisms
(SNPs) of the HFE gene form intragenic haplotypes be-
cause this gene is located on the short arm of human
chromosome 6, 4 megabases from the major histocom-
patibility complex (MHC) on the telomeric side. This
human-genome locus codes for human leukocyte anti-
gens (HLA) and is characterized by a significant linkage
disequilibrium and a high polymorphism level at the
same time. The recombination rate is 5-fold lower than
the average in this segment of the human genome [1]. It
has been shown that some HFE haplotype frequencies
are race specific and hence can be used in phylogenetic
analysis [2–5]. The common designations of the HFE
SNPs under study and their genetic identifiers are shown
in Table 1.
As shown previously, only 4 HFE intronic haplotypes
for rs2071303, rs1800708, and rs1572982 (TTG, CTA,
CCA, and TTA) occur in populations of Russia, each
of the mutations (C282Y, H63D, and S65C) is in a link-
age disequilibrium only with one of the intronic haplo-
type variants: TTG, CTA, and CCA, respectively [5].
Genotyping for these 6 SNPs (rs1799945, rs1800730,
rs1800562, rs2071303, rs1800708, and rs1572982) in
several Northern Eurasian ethnic groups revealed an
increased frequency of the “youngest” and less poly-
morphic CCA haplotype among Asians compared to
Caucasoids. Of note, South-East Asian populations
also have high CCA frequency [2, 4] despite different
routes of colonization in North and South Asia [6, 7].
This phenomenon may be explained either by a
founder effect in an ancestral population that gave rise to
the entire Asian race or by convergent selection at the be-
ginning of (or even during) settling of Asia. The T-to-C
substitution in rs1800708 is specific for this haplotype,
and may change probability of formation of soluble HFE,
because of its location in 1 of 4 nearby alternative donor
splice sites in intron 4 of the HFE gene. The use of this al-
ternative splice site leads to expression of HFE mRNA
with retained intron 4 and production of a shortened pro-
tein formation [5]. It is known that truncated soluble HFE
can associate with soluble transferrin receptor 1 [8]; in
addition, soluble HFE regulates hephaestin expression [9].
It is known that excess free iron in the body leads to oxi-
dative stress, increasing inflammation, necrosis, and apop-
tosis. On the other hand, iron deficiency anemias can cause
immune disorders and impairment of thermoregulation
and may promote carcinogenesis and psychomotor and
cognitive aberrations in children [10–12]. The HFE protein
is one of the key regulators of iron metabolism. It regulates
capture of transferrin-bound iron from plasma and expres-
sion of the iron-regulatory hormone hepcidin [13]. De-
creased expression of the HFE gene or misfolded HFE
protein can increase iron transport from enterocytes
to the bloodstream and iron uptake by all cells pos-
sessing transferrin receptors (especially by hepato-
cytes). In combination with increased dietary intake
of iron, the above condition can cause iron overload
and then hemochromatosis, which is mainly charac-
terized by iron deposition in parenchymal tissues,
hepatomegaly, cirrhosis, diabetes mellitus, and skin
hyperpigmentation. C282Y/C282Y genotype carriers
constitute up to 100 % of patients with hereditary
hemochromatosis. Nonetheless, clinical penetrance of
hereditary hemochromatosis among C282Y homozy-
gotes is incomplete in human populations and de-
pends on other genetic and environmental factors
[14]. In addition, it was shown that frequencies of
C282Y and H63D alleles are increased among pa-
tients with various cancers and metabolic distur-
bances; in particular, the H63D mutation of the HFE
gene alters cholesterol metabolism [15]. This phenomenon
is usually explained by adverse effects of oxidative stress
and immune disorders in carriers of these mutations [16].
Nevertheless, the presence of the same mutations can pro-
vide a protective effect against anemia in geographical re-
gions with frequent iron deficiency [17].
During settlement of human populations across the
planet, these populations underwent many bottlenecks
with reductions in size and large migrations of people.
Migration out of Africa, settling of new climatic zones,
domestication of animals, and the agricultural revolution
caused dietary changes necessary to adapt to new patho-
gens and new climatic conditions and possibly to de-
velop cognitive abilities [18, 19]. The continental climate
of Northern Asia resulted in human adaptation to low
humidity; frequent fluctuations in atmospheric pressure,
temperature, and insolation; and to reduced availability
of plant food. During the spread of humans across Asia,
selection for certain adaptive traits could have been one
of the reasons for formation of the Asian race.
We assumed that haplotype analysis in Caucasoid
patients—living now in Western Siberia and having dis-
eases associated with dietary habits and metabolic
Table 1 Genetic identifiers, locations in the HFE gene, and common designations of the SNPs under study
SNP Location SNP Location SNP Location
rs2794719 Intron 1 rs2071303 Intron 2, IVS2(+4)t/c rs1800562 Exon 4, C282Y
rs1799945 Exon 2, H63D rs2032451 Intron 3 rs1800708 Intron 4, IVS4(−44)t/c
rs1800730 Exon 2, S65C rs807209 Intron 3 rs1572982 Intron 5, IVS5(−47)a/g
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rate—will allow us to understand the processes of possible
selection during settling of the northern part of Asia.
Patients with various lipid metabolism disorders were
selected because lipid metabolism strongly affects energy
balance, capacity for cold adaptation, and survival during
long-term nutritional restriction. In particular, patients
with a combination of metabolic syndrome and arterial
hypertension were genotyped here because it is believed
that predisposition to hypertension in humans is a con-
sequence of maladaptation during settling of cold cli-
matic zones [18].
Metabolic syndrome (MS) is a complex metabolic dis-
order that increases the risk of cardiovascular disease
and diabetes. MS’s main diagnostic feature is abdominal
obesity; in addition, patients may have high blood pres-
sure, elevated plasma levels of triglycerides, and low
levels of high-density lipoprotein cholesterol and fasting
plasma glucose in various combinations. MS patients
show elevated levels of systemic inflammation markers
and hepcidin [20, 21].
Fatty liver disease (FLD) is a liver disorder that is char-
acterized by fat accumulation in hepatocytes. It can proceed
with or without the effects of insulin resistance [22].
Type 2 diabetes mellitus (T2DM) constitutes 85–90 %
of all cases of diabetes and is associated with obesity or
overweight in most cases. It is characterized by hypergly-
cemia in the context of insulin resistance and a relative
deficit of insulin [21].
To estimate the possible influence of different HFE al-
leles on the development of cancer associated largely
with cooking methods and dietary habits, a group of pa-
tients with stomach cancer was genotyped here.
Stomach cancer is a malignant tumor developing in
the gastric epithelium. The main risk factors of stomach
cancer are Helicobacter pylori infection, smoking, and
genetic predisposition. Inappropriate dietary habits such
as consumption of high-salt foods, fried or stewed
creatinine-containing foods (e.g., red meats), low con-
sumption of fruit and vegetables, and iron deficiency
anemia are additional risk factors [11, 23].
In this study, we analyzed the distribution of intragenic
haplotypes and genotypes of the HFE gene i) among re-
cently settled and indigenous Northern Eurasian popula-
tions and ii) in patients with metabolic disorders and
among long-lived people. We tested the hypothesis that
some HFE gene alleles were under positive selection pres-
sure or hitchhiked with some HLA-A haplotype under
specific environmental conditions of Northern Eurasia.
Results and discussion
HFE haplotype analysis
The genotyping data on rs1799945 (H63D), rs1800730
(S65C), rs1800562 (C282Y), rs2071303, rs1800708, and
rs1572982 of the HFE gene in Siberian populations and
in patients are summarized in Table 2. These data were
used for construction of Pearson’s matrix (Additional
file 1: Table S1) and a multidimensional scaling (MDS)
plot of genetic similarities (Fig. 1).
There is a correlation between genetic distances in
Fig. 1 and geographic locations of the Asian populations
analyzed. Nanaians, Nivkhs, Koryaks, Evenks, Eskimos,
and Yukaghirs inhabit the eastern part of Northern Asia.
Shorians, Khakas, Yakuts, and Siberian Tatars are re-
ferred to as Turkic peoples. Shorians, Khakas, and Tatars
are the inhabitants of Western Siberia; Yakuts mi-
grated to their present geographic area in the Sakha
(Yakutia) Republic from South Siberia in the 13th cen-
tury. Siberian Tatars are characterized by intermediate
anthropological and genetic features between Caucasoids
and Asians. Ethnic Russians began to spread across Siberia
at the end of the 19th century; Germans were resettled to
South Siberia from the European part of Russia in the
20th century. Populations of Eastern Siberia and Altai
Germans (they originated in Western Europe) are the
most genetically distant groups. Turkic peoples (including
Tatars) and ethnic Russians are between them in the plot.
Our groups of patients lie near the ethnic Russian popula-
tion on the MDS plot (Fig. 1).
The HFE haplotype frequencies for rs1799945 (H63D),
rs1800730 (S65C), rs1800562 (C282Y), rs2071303,
rs1800708, and rs1572982 in the groups under study are
summarized in Table 3.
The genotype distribution in all populations is in
Hardy-Weinberg equilibrium with the exception of
Khakas for CTA WT (χ2 P value 0.021), Germans and
Shorians for TTG WT (χ2 P value 0.0138 and 0.0051,
respectively), and Koryaks for CCA WT (χ2 P value
0.023). The deviation from Hardy-Weinberg equilib-
rium in the Khakas group is probably caused by low
frequency of the CTA WT allele and small sample size.
Germans, Shorians, and Koryaks inhabit isolated ethnic
settlements, with the possibility of marriages between
relatives. This state of affairs can explain the Hardy-
Weinberg deviations in these groups.
HLA-typing of the CCA haplotype homozygotes for
rs2071303, rs1800708, and rs1572982
In Table 3, a west–east gradient of the CCA WT haplo-
type’s frequency can be seen among Asian populations.
East Asian Evenks, Koryaks, and Eskimos have a higher
CCAWT frequency than do Central Asian Tartars,
Shorians, Khakas, and Yakuts. The reason for formation
of such a gradient may be a genetic drift because it is
known that geographic distance to East Africa corre-
lates with the loss of genetic and phenotypic heterogen-
eity [6, 24, 25]. Besides, an increase in the CCA
haplotype frequency may be possible both because of
hitchhiking and as a result of positive selection owing
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Table 2 The genotyping data on rs1799945 (H63D), rs1800730 (S65C), rs1800562 (C282Y), rs2071303, rs1800708, and rs1572982 of the HFE gene in Northern Asian populations
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to possible changes in regulation of HFE expression.
This is because change in gene expression drives hu-
man adaptation 10-fold more likely than changes in
amino acid sequence [26]. The most likely candidates
for hitchhiking are HLA class I genes. It was proven
that they are under strong selection pressure [25]. A
model of pathogen-driven balancing selection implies
maintenance of maximal heterozygosity of the HLA locus
in populations, although it has been demonstrated that
the number of HLA alleles depends on a pathogen’s (espe-
cially a virus’s) richness in a certain area [27, 28].
HLA typing is a widespread method for haplotype ana-
lysis of the MHC locus. Some HFE alleles were found to
be in linkage disequilibrium with certain HLA haplo-
types. The C282Y, H63D, and S65C mutations of HFE
are associated with alleles HLA-A3 (43–75 %), HLA-A29
(16–27 %), and HLA-A26 of the HLA-A locus, respect-
ively [29–31]. Many of HLA haplotypes of MHC were
found to be associated with autoimmune and metabolic
disturbances and with some infectious and oncological
diseases [32]. Selection for a certain HLA haplotype dur-
ing the settling of Asia may be one of the reasons for
the growth of the number of CCA WT haplotype car-
riers among Asians. HLA-A, −B, and -C alleles were
identified in 18 homozygous CCA WT carriers. The re-
sults of HLA typing are summarized in Table 4.
In the Asian sample (28 chromosomes analyzed), CCA
was most frequently associated with HLA-A2 (39 %). A
higher-resolution kit is required for identification of al-
leles A2 and A210 (A*02010101-02/04-22/24/26/33/
36/37/39/40/42-49/51-55/57/61/63/64/66-72/7401-77/
79/81-97/99 and A*9201/02/04/06-09, respectively),
which yielded identical results here. In addition, CCA
haplotype was detected in combination with HLA-A1,
A3, A11, A24, A31, and A80 (1, 3, 1, 4, 5, and 1
chromosome, respectively). Because HLA-B and HLA-
C are located farther from HFE on the chromosome
than HLA-A is, they do not have similar statistical as-
sociations. Selection for the CCA haplotype among
Asians is hardly caused by its linkage to HLA-A2 be-
cause the latter is one of the most widespread in
Asians, Tatars, and Caucasoids [33–35].
TTG haplotype analysis
It is known that the TTG WT haplotype (T in
rs2071303, T in rs1800708, and G in rs1572982) has 3
subtypes, one of them includes 3 linked mutations in in-
tron 3 of the HFE gene, and another includes 5 linked
mutations in the 5′ untranslated region (5′UTR) and in
intron 1 [4]. For detection of a variety of TTG WT hap-
lotypes, a search for T in rs807209 and G in rs807209
was carried out. Thirteen Russians, 9 Yakuts, 25
Fig. 1 A multidimensional scaling plot of distances among populations and groups of patients on the basis of Pearson’s matrix (Additional
file 1: Table S1). MS + AH: metabolic syndrome associated with arterial hypertension, T2DM: type 2 diabetes mellitus, FLD: fatty liver disease,
LL: long-lived people
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Table 3 Amounts of HFE haplotypes and their frequencies for rs2071303, rs1800708, rs1572982, C282Y, H63D, and S65C in various
populations, groups of patients, and long-lived people
Groups TTG WT TTG C282Y CTA WT CTA H63D TTA CCA WT CCA S65C
Populations
Russian adolescents 331 16 75 118 103 59 10
0.46 0.02 0.11 0.17 0.14 0.08 0.01
Russian old believers (an isolate) 101 7 18 21 33 20 4
0.5 0.03 0.09 0.1 0.16 0.1 0.02
Germans, Altai 79a 4 26 29 13 5 4
0.49 0.03 0.16 0.18 0.08 0.03 0.03
Siberian Tatars 207 0 34 21 56 71 7
0.52 0.09 0.05 0.14 0.18 0.02
Shorians 107a 1 26 20 44 81 5
0.38 0.004 0.09 0.07 0.15 0.29 0.02
Khakas 67 1 13a 9 33 43 4
0.39 0.006 0.08 0.05 0.19 0.26 0.02
Yukaghirs 71 5 8 7 14 55 2
0.44 0.03 0.05 0.04 0.09 0.34 0.01
Yakuts 32 0 1 1 11 17 0
0.52 0.02 0.02 0.18 0.27
Nivkhs 15 0 1 3 4 35 0
0.26 0.02 0.05 0.07 0.6
Koryaks 53 0 12 3 8 86a 0
0.33 0.07 0.02 0.05 0.53
Evenks 30 0 3 2 4 37 0
0.39 0.04 0.03 0.05 0.49
Nanaians 23 0 14 5 1 23 0
0.35 0.21 0.08 0.02 0.35
Eskimos 29 0 4 0 17 34 0
0.35 0.05 0.2 0.4
Patients, Novosibirsk
MS + AG total 387 21 66 84 105 68 9
0.52 0.03 0.09 0.11 0.14 0.09 0.01
MS + AH, women 243 12 36 54 77 48 2
0.51 0.03 0.08 0.11 0.16 0.1 0.004
MS + AH, men 144 9 30 28 28 20 7
0.54 0.03 0.11 0.11 0.11 0.08 0.03
Fatty liver disease 78 6 15 17 17 10 5
0.53 0.04 0.1 0.11 0.11 0.07 0.03
T2DM 172 6 32 46 28 20 6
0.55 0.02 0.1 0.15 0.09 0.06 0.02
Stomach cancer 154 6 38 40 38 22 2
0.51 0.02 0.13 0.13 0.13 0.07 0.01
Long-lived people
total 270 9 47 63 66 51 2
0.53 0.02 0.09 0.12 0.13 0.1 0.004
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Shorians, 9 Khakas, 2 Kazakhs, and 35 Tatars homozy-
gous for the TTG WT allele were analyzed for rs807209
because it was previously detected in Africans [4]. T in
rs807209 was not found in these 186 chromosomes. Ra-
ther, the results showed a lack of haplotypes containing
it among Caucasoid and Northern Asian populations at
appreciable frequencies.
Another TTG haplotype with 5 linked mutations in
the 5′UTR and intron 1 seems to be the second most
common among all Europeans. It is in this haplotype
that the C282Y mutation arose. Additionally, the same
combination of polymorphisms was found in the CTA +
H63D and all CCA haplotypes. It is believed that these
identical mutations arose in different haplotypes via re-
combination events [4]. A total of 163 chromosomes
(103 ethnic Russian and 60 Asian chromosomes, includ-
ing 20 Khakas, 12 Eskimos, 4 Nivkhs, 8 Nanaians, and
16 Chukchis) carrying the TTG WT haplotype were ana-
lyzed for rs2794719 in intron 1 of HFE. The frequency
of G in rs2794719 among TTG WT chromosomes was
0.38 in ethnic Russians and 0.13–0.42 in Asians.
Thus, there is no significant difference in frequencies
of 3 known subtypes of the TTG haplotypes between
Asian and Caucasoid TTG WT chromosomes in the
Northern part of Eurasia.
CTA haplotype analysis
Chromosomes carrying the H63D mutation were ana-
lyzed for rs2032451. This SNP occurs among Europeans
with the frequency of ~0.17 according to data at
http://www.ncbi.nlm.nih.gov. The genotyping results
are presented in Table 5.
All 5 H63D homozygotes had T/T in rs2032451; all 83
H63D heterozygotes had G/T. In carriers of other geno-
types, no T was detected in rs2032451. On the other
hand, verification of possible presence of this SNP in
some other haplotypes requires bigger cohorts. These
findings confirmed the data on a linkage between
rs1799945 and rs2032451 that were previously obtained
in a small sample [4]. The H63D mutation seems to be
associated with T in rs2032451 in addition to the
previously described CTA haplotype for rs2071303,
rs1800708, and rs1572982 of the HFE gene in most
of human populations of Eurasia.
Thus, it was confirmed that the maximal difference in
allele frequency between Asians and Caucasoids is ob-
served in the CCA haplotype of HFE (3–8 % vs. 27–
60 %). Siberian Tatars show an intermediate frequency
(18 %). Furthermore, there is a significant difference in
the frequency of the CTA haplotype containing the
H63D mutation (10–18 % among Caucasoids vs. 0–8 %
among Asians). Frequencies of other detected haplotypes
showed ethnic differences comparable with interracial
ones. This finding allowed us to hypothesize a selection
in rs1800708 and rs1799945 during the split of the Asian
race and Caucasian race. The HFE protein with H63D
fails to induce hepcidin expression via the bone-
morphogenic-protein pathway [36]. It is known that
H63D is associated with several neurodegenerative dis-
eases and porphyria cutanea tarda [37–39]. The reasons
for the widespread occurrence of H63D in European
populations are not clear. Because monophyletic origin
of H63D was proven in Caucasoids and North Eurasian
Table 3 Amounts of HFE haplotypes and their frequencies for rs2071303, rs1800708, rs1572982, C282Y, H63D, and S65C in various
populations, groups of patients, and long-lived people (Continued)
men 57 2 9 13 19 8 0
0.53 0.02 0.08 0.11 0.18 0.07
women 213 7 38 50 47 43 2
0.53 0.02 0.1 0.13 0.12 0.11 0.005
WT are gene variants without the exonic SNPs; MS + AH: metabolic syndrome associated with arterial hypertension, T2DM: type 2 diabetes mellitus, adeviations
from Hardy-Weinberg equilibrium
Table 4 HLA genotypes in CCA/CCA haplotype carriers
Ethnic groups HLA-A HLA-B HLA-C
Russians A1/A3 B35/B58 Cw4/Cw7
A3/A3 B35/B35 Cw4/Cw4
Tatars A2/A24 ND Cw2/Cw8
A11/A24 B60/ND Cw9/Cw9
Tuvinians A2/A2 B61//ND Cw6/Cw8
A2/A11 B46/B60 Cw1/Cw10
Shorians A2/A24 B56/B61 Cw1/Cw6
A3/A31 B7/B41 Cw8/Cw8
Khakas A2/A24 ND Cw10/Cw10
A2/A24 B60/ND Cw1/Cw10
Yakuts A2/A24 B61/B61 Cw10/Cw10
A31/A31 ND Cw9/Cw9
Koryaks A2/A31 B27/B61 Cw2/Cw10
A2/A24 B48/B48 Cw7/Cw8
Altaian A1/A2 B44/B6 Cw5/Cw7
Kazakh A2/A80 ND Cw7/Cw8
Evenks A3/A3 B35/B35 Cw4/Cw4
A31/A31 B21/B48 Cw8/Cw10
ND not determined
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Asians, it can be supposed that H63D was under nega-
tive selection pressure in Asia. No changes were demon-
strated in the structure of the HFE protein of the CCA
haplotype without the S65C mutation. On the other
hand, we previously found that C in rs1800708 (which is
crucial for this haplotype) is located in a potential alter-
native donor splice site and may alter the probability of
production of a soluble HFE protein [5].
Genetic analysis of the patients and long-lived people
The results on genotyping of patients with MS, T2DM,
FLD, or stomach cancer and long-lived people are sum-
marized in Table 3 too. As mentioned above, patients
with metabolic disturbances associated with overweight
or obesity tend to have iron metabolism disorders. The
increased serum ferritin and hepcidin levels are observed
in MS subjects [40]. Patients with 4 or more signs of MS
show more than a 4-fold increase in concentration of
hepcidin (iron regulatory hormone). Normally, its con-
centration can increase in response to an infection and
causes restriction of iron release from the cells into the
bloodstream. This change inhibits proliferation of vi-
ruses and bacteria but can cause anemia of chronic dis-
eases. Such a metabolic change is expected to worsen
insulin resistance and promote cardiovascular complica-
tions in patients with MS. Apparently, a mutation in the
HFE gene, which is a hepcidin regulator, can affect both
the probability of MS development and the course of the
disorder [40]. An association between the H63D muta-
tion of HFE and essential hypertension was described
in a Finnish cohort [41]. Data on the association of
HFE and predisposition to T2DM and/or its complica-
tions are different depending on a population. Most
likely, the effect of the HFE mutations is race specific
[42]. Patients with FLD show increased H63D
frequency in Korea [43]. In contrast, we observed no
significant differences between patients and the control
in frequencies of alleles C282Y, H63D, and S65C. Thus,
the presence of these mutations has no effect on pre-
disposition to AH, FLD, T2DM, or stomach cancer in
Novosibirsk patients. Among the latter, however, more
detailed tumor typing is required, so that risk factors
(including dietary habits) can be specifically attributed
to different subtypes [23]. The observed lack of a differ-
ence between the patients and the general population
in frequencies of alleles C282Y, H63D, and S65C can be
caused by a widespread iron deficiency anemia in the
residents of Siberia [44]. This anemia may also attenu-
ate the effect of the low-penetrance mutations on a
phenotype. Frequency of the H63D allele in the adoles-
cent sample, however, was higher than previously re-
ported for adult Russians in Novosibirsk city and for
the European part of Russia (0.17 vs. 0.13 and 0.15, re-
spectively) [5, 45]. This frequency was found to be sig-
nificantly different from the frequency in the sample of
long-lived people (P = 0.016). In a comparison of long-
lived people with adult population groups in Novosi-
birsk city, a decrease in C282Y frequency was noted
among long-lived people [46]. We found no such differ-
ence in the frequency of C282Y between long-lived
people and adolescents. The differences in frequencies
of the HFE alleles—as a function of average age in a
group—require further analysis.
We did not detect a difference in the CCA WT allele
frequency between any populations and groups of pa-
tients among Russians (Table 3). It is possible that selec-
tion for specific variants in this locus may facilitate
adaptation to infections and parasites because adaptation
to pathogens is considered the most significant during
human evolution [10, 19, 47].
Table 5 The rs2032451 polymorphism among H63D carriers
Ethnic
groups
H63D+/+ Number H63D+/− Number H63D−/− Number
rs2032451 rs2032451 rs2032451
Russians T/T 3 G/T 9 G/G 8
Tatars T/T 1 G/T 18
Mansis G/T 5
Nanaians G/T 5 G/G 6
Nivkhs G/T 3 G/G 5






Total 5 83 19
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Our results revealed that frequencies of the TTA
haplotype of rs2071303, rs1800708, and rs1572982 of
HFE in all groups of patients whose disorders are as-
sociated with overweight or obesity (with the excep-
tion of MS + AH women) are lower than those in the
groups of adolescents, elderly people (old-believers,
average age 70), and long-lived men. Significant dif-
ferences in this haplotype’s frequency were found be-
tween the T2DM sample and the groups of
adolescents, elderly citizens, and long-lived people
(P = 0.003, 0.01, and 0.015, respectively). Nonetheless,
the TTA haplotype’s frequency in the groups of Rus-
sian patients was close to its frequency in the Altai
German population (Table 3). This result shows vari-
ability of the TTA frequency among Caucasoids and,
possibly, its ethnic specificity among the patients.
Most likely, the observed difference in the TTA fre-
quency is not due to differences in iron metabolism.
It is possible that one of common subtypes of the
TTA haplotype is linked to MHC genes or any other
nearby genes that have protective effects against
overweight or some obesity-related complications.
The TTA haplotype frequencies differ significantly
between men and women in MS + AH groups (P =
0.047). Elucidation of the reasons for these genetic
differences requires a more detailed study. The MS +
AH female sample may be more genetically heteroge-
neous than the male one.
Conclusions
The reasons for a sharp increase in the frequency of the
CCA haplotype of the HFE gene in the Asian race re-
main unknown. In 39 % of cases, this haplotype is linked
with HLA-A2 in Asians, but HLA-A2 is a common
HLA-A allele everywhere. It is not clear whether the ob-
served gradient of the CCA WT frequency is a conse-
quence of genetic drift on the territory of Northern
Eurasia or a result of selection for this allele, which is
characterized by some additional capabilities of gene ex-
pression regulation. Perhaps analysis of patients with in-
fectious diseases that are widespread in the region will
allow researchers to answer this question. Frequencies of
the TTA haplotype of the HFE gene—in the groups of
patients whose disorders are associated with over-
weight—are lower than such frequencies in Russian pop-
ulations. This topic requires a more detailed study. No
significant differences in frequencies of the alleles with
mutations in coding regions of HFE (C282Y, H63D, and
S65C) were detected between the analyzed groups of pa-
tients (with stomach cancer, metabolic syndrome, fatty
liver disease, or type 2 diabetes mellitus) and the control
sample. Monophyletic origin of H63D (rs1799945) was
confirmed in Caucasoids and Northern Asians.
Methods
Populations studied
The control adolescent sample (356 individuals) aged
14–17 years of both sexes was selected from the inhabi-
tants of Novosibirsk city. The German sample was
drawn from the inhabitants of a German settlement in
Altai region (Veseloyarsk settlement) and consists of 80
individuals. The Siberian Tatar sample (196 people) was
selected in the Novosibirsk region, Chanovsky district.
Tatars are a Turkic people, which have intermediate an-
thropological and genetic features between Caucasoids
and Asians. Native Asian groups were selected from
Western Asian peoples, including Shorians (142 individ-
uals, Kemerovo region, Tashtagol district), Khakas (85
individuals, Republic of Khakassia, Abakan town), Yakuts
(31 individuals Sakha [Yakutia] Republic, Namtsy settle-
ment), and from Eastern Asian peoples, including
Yukaghirs (81 individuals, Sakha [Yakutia] Republic,
Verhnekolymsky district, Nelemnoe settlement), Evenks
(38 individuals, Amur region, Tyndinsky district),
Nivkhs (29 individuals, Sakhalin region, Noglinsky dis-
trict), Koryaks (81 individuals, Kamchatka Krai, Ossora
settlement), Eskimos (42 individuals, Chukotka Au-
tonomous Okrug, Chukotsky district), and Nanaians
(33 individuals, Khabarovsk region). In addition, we an-
alyzed the sample of Russian old believers (102 individ-
uals), average age 70. This population chose to live in
isolation since the 17th century in Kurgan region
(South Ural).
The groups of Altaians and Kazakhs (Altai Republic,
Kosh-Agach region), Chukchi (Chukotka Autonomous
Okrug), and Mansi (Finno-Ugric people from the basin
of the Ob river) that were previously genotyped for SNPs
rs1799945, rs1800730, rs1800562, rs2071303, rs1800708,
and rs1572982 [5] were partly used in the analysis for
SNPs rs2032451, rs2794719, and rs807209.
Ethnicity of individuals was identified using question-
naires and additional cross-examination with elucidation
of a nationality of ancestors (at least in 3 generations).
Groups of patients
The sample of patients with MS consisted of 236 women
(average age 59, mean body-mass index [BMI] 34) and
133 men (average age 58, mean BMI 30). In this study,
only patients with arterial hypertension (systolic arterial
pressure greater than 140 mmHg and diastolic one
greater than 90 mmHg) were enrolled. The sample was
drawn randomly from the cohort of Caucasoid inhabi-
tants of the Oktyabr’skii district of Novosibirsk city (age
45–69 years), which were found during the HAPIEE
project (Health, Alcohol, and Psychosocial factors In
Eastern Europe) [48]. The T2DM sample consisted of 68
women and 87 men (average age 59, mean BMI among
males: 31, females: 32). The sample was randomly
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selected from the HAPIEE. Individuals were assumed to
have T2DM if they had a glucose level above 11 mM
after a 2-hour oral glucose tolerance test. The sample
of patients with FLD included 74 individuals from
Novosibirsk city (men’s average age 47 and mean BMI
33; women’s average age 54 and mean BMI 35). The
sample of patients with stomach cancer was drawn
from the patients of Novosibirsk city and included 150
patients (men and women equally) who had various
histological types of stomach cancer (the average age of
males was 56, females 58). All patients had a physician-
confirmed diagnosis. The sample of long-lived people
consisted of 200 women and 54 men aged 90–105 years
from cities Novosibirsk, Tomsk, and Tumen.
No differences between men and women were ob-
served in the HFE allele frequencies in groups stomach
cancer, T2DM, and FLD; the same was true for the ado-
lescent and old-believer groups; therefore, the two gen-
ders were combined there.
Genetic analysis
The group analysis for rs1799945, rs1800730, rs1800562,
rs2071303, rs1800708, and rs1572982 and identification
of HFE haplotypes were performed by PCR with analysis
of restriction fragment length polymorphism as de-
scribed elsewhere [5]; 2 298 individuals were analyzed.
The analysis for rs2032451 in intron 3 of HFE was per-
formed by PCR-RFLP using primers 5′-GGCCTCAC
TTGATATTTTGTCCTGG-3′ and 5′-GGCCCTTGCT
TTTTATTTAACC-3′ and the BsuRI restriction endo-
nuclease. Analysis for rs2794719 in intron 1 of HFE was
performed by PCR-RFLP using primers 5′-TCCTGGC
AAATTTATTCAATGGTCC-3′ and 5′-GTTTCCCTGC
TCTCTCCCTTG-3′ and the BssEcI restriction endo-
nuclease. Analysis for rs807209 in intron 3 of HFE was
performed using a 7900HT StepOnePlus Real-Time PCR
System and TaqMan® SNP Genotyping Assays (Applied
Biosystems, USA).
HFE haplotype analysis
As shown previously, only 4 HFE intronic haplotypes of
rs2071303, rs1800708, and rs1572982 (TTG, CTA, CCA,
and TTA) occur in populations of Russia; each of the
mutations (C282Y, H63D, and S65C) was in linkage dis-
equilibrium only with one of the intronic haplotype vari-
ants: TTG, CTA, and CCA, respectively [5]. This
situation allowed us to identify intragenic HFE haplo-
types by analyzing the groups for rs1799945, rs1800730,
rs1800562, rs2071303, rs1800708, and rs1572982.
HLA typing
HLA typing was performed using the HLA-ABC Low
Res Kit (Invitrogen, USA). Eighteen homozygous car-
riers of the CCA intragenic haplotype without the
S65C mutation were thus analyzed, including 2 ethnic
Russians, 2 Siberian Tatars, 2 Evenks, 2 Khakas, 2
Shorians, 2 Koryaks, 2 Yakuts, 2 Tuvinians, 1 Altaian,
and 1 Kazakh (the last 4 individuals are from previ-
ously genotyped groups of Central Asian peoples [5]).
Statistical analysis
The populations were tested for Hardy-Weinberg equi-
librium by Pearson’s χ2 test. Haplotypic frequencies were
compared between the studied groups by χ2 test in the
SPSS 16.0 software. A difference between two groups
was considered significant at a P value <0.05.
An MDS plot was constructed on the basis of Pearson’s
pairwise correlation matrix between the genotype fre-
quency profiles (Additional file 1: Table S1). The XLStat
package (www.xlstat.com) was used to produce both Pear-
son’s correlation matrix and the MDS plot. For MDS, the
absolute values of Pearson’s correlation were used. The
target minimization function was Kruskal’s stress statistic;
initial configuration was set to “random”; the number of
repetitions was 5; the convergence threshold was set to
0.00001, with the maximal number of iterations 500.
Additional file
Additional file 1: Table S1. Pearson’s correlation matrix between HFE
genotype frequency profiles. Values in bold are different from 0 with a
significance level alpha = 0.05. MS + AH: metabolic syndrome associated
with arterial hypertension, T2DM: type 2 diabetes mellitus, FLD: fatty liver
disease, St. cancer: stomach cancer, LL: long lived. (XLSX 13 kb)
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